SIGLEC15 and neoplasm: The results demonstrated a positive correlation between FANCD2 and immune checkpoints in most tumor tissues, including CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, SIGLEC15, TIGIT, and particularly CD274 (Fig. 5A).